Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (591-600 of 751) with videos related to

Pageof 76
Sort By:
American Heart Journal|December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trialJeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
Journal of Cardiac Failure|April 10, 2024
Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HFSatoshi Shoji, Lisa A Kaltenbach, Bradi B Granger, et al.
European Heart Journal|February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
Journal of the American Heart Association|June 3, 2022
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS TrialVictor J Del Brutto, Han-Christoph Diener, J Donald Easton, et al.
American Heart Journal|August 28, 2025
REview and improvement of Cardiac implanTable device InFection management qualitY initiative (RECTIFY): Rationale and Design for a Cardiac Implantable Electronic Device Infection Quality Initiative Demonstration ProjectNkiru Osude, Christopher B Granger, Rebecca Young, et al.
JAMA|June 10, 2004
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryKim A Eagle, Michael J Lim, Omar H Dabbous, et al.
JACC. Heart Failure|April 15, 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, Pardeep S Jhund, Kieran F Docherty, et al.
Journal of Thrombosis and Thrombolysis|February 7, 2012
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialSean van Diepen, Matthew T Roe, Renato D Lopes, et al.
American Heart Journal|December 22, 2005
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trialsJohn M Galla, Kenneth W Mahaffey, Shelly K Sapp, et al.
Journal of the American College of Cardiology|October 11, 2014
Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trialGreg Flaker, Renato D Lopes, Elaine Hylek, et al.
Pageof 76

Showing results (591-600 of 751) with videos related to

Sort By:
Pageof 76
American Heart Journal|December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trialJeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
Journal of Cardiac Failure|April 10, 2024
Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HFSatoshi Shoji, Lisa A Kaltenbach, Bradi B Granger, et al.
European Heart Journal|February 6, 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1Hans-Christoph Diener, James Aisenberg, Jack Ansell, et al.
Journal of the American Heart Association|June 3, 2022
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS TrialVictor J Del Brutto, Han-Christoph Diener, J Donald Easton, et al.
American Heart Journal|August 28, 2025
REview and improvement of Cardiac implanTable device InFection management qualitY initiative (RECTIFY): Rationale and Design for a Cardiac Implantable Electronic Device Infection Quality Initiative Demonstration ProjectNkiru Osude, Christopher B Granger, Rebecca Young, et al.
JAMA|June 10, 2004
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryKim A Eagle, Michael J Lim, Omar H Dabbous, et al.
JACC. Heart Failure|April 15, 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, Pardeep S Jhund, Kieran F Docherty, et al.
Journal of Thrombosis and Thrombolysis|February 7, 2012
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trialSean van Diepen, Matthew T Roe, Renato D Lopes, et al.
American Heart Journal|December 22, 2005
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trialsJohn M Galla, Kenneth W Mahaffey, Shelly K Sapp, et al.
Journal of the American College of Cardiology|October 11, 2014
Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trialGreg Flaker, Renato D Lopes, Elaine Hylek, et al.
Pageof 76